Monte Rosa Therapeutics, Inc. - Common Stock (GLUE)
4.8500
-0.1000 (-2.02%)
NASDAQ · Last Trade: Apr 29th, 10:28 AM EDT
Monte Rosa's MRT-6160 shows promising Phase 1 results, with Novartis backing its development in a deal that could reach $2.1B in milestone payments.
Via Benzinga · March 20, 2025

The companies will collaborate on a molecular glue degrader, a potential treatment for autoimmune diseases.
Via Investor's Business Daily · October 28, 2024

Via Benzinga · October 28, 2024

Via Benzinga · October 28, 2024

Monte Rosa Therapeutics stock rises as it announces a global licensing deal with Novartis to advance MRT-6160 for immune conditions.
Via Benzinga · October 28, 2024

Via Benzinga · October 28, 2024

GLUE stock results show that Monte Rosa Therapeutics beat analyst estimates for earnings per share and beat on revenue for the second quarter of 2024.
Via InvestorPlace · August 8, 2024

Via Benzinga · May 16, 2024

Via Benzinga · May 15, 2024

GLUE stock results show that Monte Rosa Therapeutics beat analyst estimates for earnings per share but missed on revenue for the first quarter of 2024.
Via InvestorPlace · May 9, 2024

Via Benzinga · March 26, 2024

Shares of Westport Fuel Systems Inc. (NASDAQ: WPRT) fell sharply during Tuesday’s session after posting a wider-than-expected fourth-quarter loss. Westport Fuel Systems posted a quarter loss of 81 cents per share, compared to market expectations for a loss of 51 cents per share.
Via Benzinga · March 26, 2024

GLUE stock results show that Monte Rosa Therapeutics missed analyst estimates for earnings per share the fourth quarter of 2023.
Via InvestorPlace · March 14, 2024

Wedbush initiates coverage on Monte Rosa Therapeutics. With differentiated lead programs and AI-driven QuEEN platform, the company shows strong potential for value creation.
Via Benzinga · February 15, 2024

Analysts have high hopes for these three innovation companies in 2024.
Via The Motley Fool · January 16, 2024

U.S. stocks traded slightly higher, with the Dow Jones index gaining over 20 points on Wednesday. Shares of Veradigm Inc. (NASDAQ: MDRX) shares fell sharply during Wednesday’s session.
Via Benzinga · January 10, 2024

Via Benzinga · December 14, 2023

Via Benzinga · December 13, 2023

U.S. stocks traded mostly lower toward the end of trading, with the Nasdaq Composite falling around 50 points on Tuesday. The Dow traded down 0.09% to 33,954.39 while the NASDAQ fell 0.37% to 13,517.59. The S&P 500 also fell, dropping, 0.10% to 4,369.41.
Via Benzinga · October 17, 2023

Gainers SciSparc Ltd. (NASDAQ: SPRC) shares climbed 146.2% to $6.97. Aegis Capital Corp. acted as exclusive placement agent on a $5.0 million private placement for SciSparc.
Via Benzinga · October 17, 2023

Via Benzinga · October 17, 2023

U.S. stocks traded mostly higher midway through trading, with the Dow Jones falling gaining around 100 points on Tuesday. The Dow traded up 0.31% to 34,090.15 while the NASDAQ fell 0.05% to 13,560.52. The S&P 500 also rose, gaining, 0.25% to 4,384.43.
Via Benzinga · October 17, 2023